News

Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the ...
Diagnos Inc. ('DIAGNOS” or the 'Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the early detection of retinal and systemic diseases, ...
A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be ...
PIP and ADP offer weekly support ranging from £29.20 to £187.45, equating to approximately £116.80 or £749.80 every four-week ...
If you have daily living and/or mobility needs due to a sight condition or low vision, you might be eligible for PIP or ADP ...
“The SMART AI application enables ophthalmologists to streamline patient screening, empowers primary care providers to ...
(“Avant” or the“Company”) and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence ...